Humacyte Inc (HUMA)
4.94
-0.15
(-2.95%)
USD |
NASDAQ |
Jun 25, 16:00
4.94
0.00 (0.00%)
After-Hours: 18:56
Humacyte Net Income (Annual): -110.78M for Dec. 31, 2023
Net Income (Annual) Chart
Historical Net Income (Annual) Data
Date | Value |
---|---|
December 31, 2023 | -110.78M |
December 31, 2022 | -11.96M |
Date | Value |
---|---|
December 31, 2021 | -26.48M |
December 31, 2020 | -66.52M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Annual) Range, Past 5 Years
-110.78M
Minimum
2023
-11.96M
Maximum
2022
-53.94M
Average
-46.50M
Median
Net Income (Annual) Benchmarks
Aquestive Therapeutics Inc | -7.87M |
Revance Therapeutics Inc | -323.99M |
AN2 Therapeutics Inc | -64.73M |
NovaBay Pharmaceuticals Inc | -9.64M |
Palatin Technologies Inc | -27.54M |